CVS Health’s iShares Core High Dividend ETF HDV Stock Holding History

CVS Health’s Portfolio HDV Stock Details HDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,365,550	Closed	-$32.1M	–	4
2024 Q3	$32.1M	Hold	1,365,550	–	–	13.95%	3
2024 Q2	$29.7M	Hold	1,365,550	–	–	13.69%	3
2024 Q1	$30.1M	Hold	1,365,550	–	–	14.21%	3
2023 Q4	$27.9M	Sell	1,365,550 -168,405	-11%	-$3.32M	14.38%	3
2023 Q3	$30.3M	Hold	1,533,955	–	–	16.22%	2
2023 Q2	$30.9M	Sell	1,533,955 -850,225	-36%	-$17.1M	15.99%	2
2023 Q1	$48.5M	Sell	2,384,180 -738,500	-24%	-$15.2M	28.86%	2
2022 Q4	$65.1M	Hold	3,122,680	–	–	56.12%	1
2022 Q3	$57M	Hold	3,122,680	–	–	54.78%	1
2022 Q2	$62.7M	Hold	3,122,680	–	–	52.01%	1
2022 Q1	$66.8M	Hold	3,122,680	–	–	44.83%	1
2021 Q4	$63.1M	Buy	+3,122,680	New	+$61.2M	55.18%	1

Other funds holding HDV

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MYLI

Meiji Yasuda Life Insurance Tokyo, Japan $3.01B AUM 7.86% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

SAM

Securian Asset Management St Paul, Minnesota $2.78B AUM 32.11% 1-Year Est. Return

CVS Health's HDV Position: Q4 2024 in Review

CVS Health sold out of iShares Core High Dividend ETF (HDV) in Q4 2024, closing a stake of 1,365,550 shares — an estimated $32.1M sold.

CVS Health first reported a position in HDV in Q4 2021 and held it in 12 quarters. The position peaked at $66.8M in Q1 2022. 776 funds tracked by Wall St. Rank hold HDV as of Q4 2024.

CVS Health reported no remaining iShares Core High Dividend ETF position as of Q4 2024 after selling out during the quarter.
CVS Health sold 1,365,550 iShares Core High Dividend ETF shares in Q4 2024, an estimated $32.1M.
CVS Health first reported a position in iShares Core High Dividend ETF in Q4 2021 and held it in 12 quarters.
CVS Health's iShares Core High Dividend ETF position peaked at $66.8M in Q1 2022.
776 funds tracked by Wall St. Rank held iShares Core High Dividend ETF as of Q4 2024.

Based on CVS Health's 13F filing for Q4 2024, filed 13 Feb 2025.